Stokes & Hubbell Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $3.48M | Buy |
43,114
+2,461
| +6% | +$198K | 0.73% | 42 |
|
2018
Q4 | $3.75M | Buy |
40,653
+72
| +0.2% | +$6.64K | 0.85% | 31 |
|
2018
Q3 | $3.84M | Sell |
40,581
-375
| -0.9% | -$35.5K | 0.8% | 36 |
|
2018
Q2 | $3.8M | Buy |
40,956
+364
| +0.9% | +$33.7K | 0.86% | 33 |
|
2018
Q1 | $3.84M | Sell |
40,592
-9,771
| -19% | -$925K | 0.89% | 32 |
|
2017
Q4 | $4.87M | Sell |
50,363
-98
| -0.2% | -$9.48K | 1.17% | 20 |
|
2017
Q3 | $4.48M | Buy |
50,461
+418
| +0.8% | +$37.1K | 1.16% | 20 |
|
2017
Q2 | $3.63M | Buy |
50,043
+5,759
| +13% | +$418K | 1.12% | 26 |
|
2017
Q1 | $2.89M | Buy |
44,284
+8,503
| +24% | +$554K | 0.98% | 29 |
|
2016
Q4 | $2.24M | Buy |
35,781
+893
| +3% | +$55.9K | 0.87% | 33 |
|
2016
Q3 | $2.2M | Buy |
34,888
+127
| +0.4% | +$8.01K | 0.91% | 27 |
|
2016
Q2 | $2.15M | Sell |
34,761
-92
| -0.3% | -$5.7K | 0.93% | 28 |
|
2016
Q1 | $1.99M | Buy |
34,853
+742
| +2% | +$42.4K | 0.92% | 29 |
|
2015
Q4 | $2.02M | Sell |
34,111
-119
| -0.3% | -$7.05K | 1.1% | 25 |
|
2015
Q3 | $1.86M | Buy |
+34,230
| New | +$1.86M | 1.13% | 20 |
|